MedDataX Logo

Mortality After Endoscopic Retrograde Cholangiopancreatography

NCT ID: NCT02983331

Last Updated: 2016-12-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1471 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-04-30

Study Completion Date

2016-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the investigators aimed to overview patients with specific and non-specific complications who admitted to intensive care unit following endoscopic retrograde cholangiopancreatography and had fatal course in the facility

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effectiveness and Safety of Single-session Endoscopic Stone Extraction

NCT06349954

Choledocholithiasis With Acute Cholangitis
COMPLETED NA

Efficacy and Safety of Single-session Endoscopic Stone Extraction

NCT06327126

Choledocholithiasis With Acute Cholangitis
COMPLETED

Refeeding in Post-ERCP Pancreatitis

NCT04750044

Post-ERCP Pancreatitis
UNKNOWN NA

Urgent (<24 Hours) Versus Early (24 to 48 Hours) ERCP for Patients With Mild and Moderate Acute Cholangitis

NCT05920954

Acute Cholangitis
COMPLETED NA

Value of Percutaneous Cholangioscopy After Placement of a Percutaneous Transhepatic Biliary Drainage

NCT00942630

Bile Duct Stricture Not Treatable by ERC
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators retrospectively reviewed patients who underwent elective or emergent endoscopic retrograde cholangiopancreatography at semi-prone position under pharyngeal anesthesia (lidocaine spray) with routine monitoring (including electrocardiography, non-invasive blood pressure, peripheral capillary oxygen saturation) and standard sedation protocol (midazolam 0.02 mgkg-1; fentanyl, 1 mgkg-1; propofol 1 mgkg-1) between 2011 and 2016 after approval of local ethics committee of Umraniye Training Hospital.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cholangiopancreatography, Endoscopic Retrograde Mortality Deep Sedation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

complications during procedure

patients may have anesthesia related complications during procedure

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who underwent elective or emergent ERCP at semi-prone position with routine monitoring and standard sedation protocol

Exclusion Criteria

* Patients who discharged to ward after treatment and follow-up in ICU
Minimum Eligible Age

42 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gulsah Karaoren

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gulsah Karaoren

MD

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gulsah Karaoren, MD

Role: PRINCIPAL_INVESTIGATOR

Umraniye Research Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Istanbul Umraniye Training Hospital

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Katsinelos P, Lazaraki G, Chatzimavroudis G, Gkagkalis S, Vasiliadis I, Papaeuthimiou A, Terzoudis S, Pilpilidis I, Zavos C, Kountouras J. Risk factors for therapeutic ERCP-related complications: an analysis of 2,715 cases performed by a single endoscopist. Ann Gastroenterol. 2014;27(1):65-72.

Reference Type RESULT
PMID: 24714755 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GK11

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Endoscopic Retrograde Cholangiopancreatography In Patients Older Than 65Years Old With Obstructive Jaundice: Efficacy And Outcome
NCT06093048 UNKNOWN NA
Endoscopic Ultrasound-guided Biliary Drainage for Malignant Biliary Obstruction After Failed ERCP
NCT03510754 COMPLETED
Cmplications of ERCP
NCT04062617 COMPLETED
Common Bile Duct Stone Management: What Have we Learned?
NCT02155244 COMPLETED
Optimizing the Evaluation and Management of Patients With Suspected Choledocholithiasis
NCT05141916 RECRUITING
ChOlecystectomy aFter successFul Endoscopic Common Bile Duct Stone Extraction in Elderly
NCT07001423 RECRUITING NA
Role of EUS in High Risk of Choledocholithiasis
NCT03250286 COMPLETED NA
Cholangioscopy or Conventional Techniques for Indeterminate Biliary Stenosis
NCT04840537 UNKNOWN NA
Cholangioscopic Assessment of Occluded Biliary Stent and Role of Biliary Radiofrequency Ablation
NCT03133026 UNKNOWN NA
Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction Patient
NCT02958059 UNKNOWN NA
The Relationship Between Post-ERCP-choledocholithiasis and Gallbladder Status
NCT04234126 COMPLETED
A Prospective, Randomized Study Evaluating the Effect of Biliary Stenting on EAU-FNA in Patients With Suspected Malignant Biliary Obstruction
NCT01514058 TERMINATED NA
Early Versus Late Cholecystectomy After Clearance of Common Bile Duct Stones
NCT02460315 COMPLETED NA
Percutaneous Endoscopic Biliary Exploration in Complex Biliary Stone Disease
NCT04308993 COMPLETED
Risk Factors for Post-ESWL and Post-ERCP Pancreatitis
NCT04619511 COMPLETED
EUS - Guided Choledocho-duodenostomy Versus ERCP With Covered Metallic Stents in Patients With Unresectable Malignant Distal Common Bile Duct Strictures
NCT03000855 COMPLETED PHASE2/PHASE3
The Comparison About the Response of Ursodeoxycholic Acid in Primary Biliary Cholangitis Only and Primary Biliary Cholangitis With High Immune Globulin G or Aminotransferase at West China Hospital
NCT03322943 COMPLETED
Comparison Between Pre and Intraoperative ERCP in Treatment of Common Bile Duct Stones
NCT01046552 COMPLETED NA
Effect of 8.5 F Plastic Stent Without Proximal Flap on Prevention of Post-ERCP Cholangitis
NCT02594891 COMPLETED NA
Eus-giuded Biliary Drainage With Ec-lams vs ERCP as a Primary Intervention for Endoscopic Treatment of Patinets With Distal Malignant Biliary Obstruction
NCT04099862 COMPLETED
Radiation Exposure During Endoscopic Retrograde Cholangiopancreatography
NCT02985164 COMPLETED PHASE3
Factors Associated With Increased Risk of Bacteremia and Cholangitis in ERCP With Cholangioscopy
NCT02543957 WITHDRAWN
To Compare EUS and MRCP in Detecting Choledocholithiasis in Patients of Intermediate Risk of Choledocholithiasis
NCT04173624 COMPLETED NA
EUS-guided Transenteric Drainage With a Novel Lumen-apposing Metal Stent
NCT03002051 COMPLETED NA
Biliary Drainage in Patients With Duodenal Metal Stent
NCT02376907 UNKNOWN